A significant increase in ATG13 concentrations was observed in the kidneys of the CIS-treated Gal-3 wild-type mice in comparison to Gal-3 wild-type sham control mice, indicating statistical significance (p < 0.001) (Figure 10A). The gene discussed is ATG13; the disease is in situ carcinoma.